SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
a study on HIV/AIDS
- for people ages 18 years and up (full criteria)
- at San Francisco, California
- study startedestimated completion
- Principal Investigator
- by Steven G. Deeks, M.D.
HIV Infections, HIV, Antiretroviral Agents, Drug Resistance, Multiple, Long Term Non Progression, Long Term Non Progressor, Elite Suppression, Elite Suppressor, Natural History, Observational
Lead Scientist at UCSF
- Steven G. Deeks, M.D.
Steven G. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment.
- accepting new patients
- Start Date
- Completion Date
- University of California, San Francisco
- Study Type
- Expecting 2500 study participants
- Last Updated